PTC Therapeutics Authorizes Share Repurchase Program of Up to $500 Million
PTC Therapeutics authorized a program to repurchase up to $500 million of its common stock.
PTC Therapeutics authorized a program to repurchase up to $500 million of its common stock.Key Highlights:Original SEC Filing: PTC THERAPEUTICS, INC. [ PTCT ] - 8-K - Nov. 03, 2026This is an AI-powered summary. It may contain inaccuracies.
Consider verifying important information with the source. P…